Hérvè Chambost
Inserm(FR)Inserm(FR)Aix-Marseille Université(FR)Assistance Publique Hôpitaux de Marseille(FR)Hôpital de la Timone(FR)
Publications by Year
Research Areas
Hemophilia Treatment and Research, Platelet Disorders and Treatments, Blood Coagulation and Thrombosis Mechanisms, Childhood Cancer Survivors' Quality of Life, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor(1997)766 cited
- → Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males(2019)413 cited
- → Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study(2013)321 cited
- → Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A(2005)293 cited
- → PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells(1998)184 cited
- → Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A(2023)178 cited